These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9501848

  • 1. Plasmodium falciparum: effect of chemical structure on efficacy and specificity of antisense oligonucleotides against malaria in vitro.
    Barker RH, Metelev V, Coakley A, Zamecnik P.
    Exp Parasitol; 1998 Jan; 88(1):51-9. PubMed ID: 9501848
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides.
    Barker RH, Metelev V, Rapaport E, Zamecnik P.
    Proc Natl Acad Sci U S A; 1996 Jan 09; 93(1):514-8. PubMed ID: 8552672
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles.
    Föger F, Noonpakdee W, Loretz B, Joojuntr S, Salvenmoser W, Thaler M, Bernkop-Schnürch A.
    Int J Pharm; 2006 Aug 17; 319(1-2):139-46. PubMed ID: 16713146
    [Abstract] [Full Text] [Related]

  • 4. Anti-sense oligodeoxynucleoside phosphorothioates nonspecifically inhibit invasion of red blood cells by malaria parasites.
    Ramasamy R, Kanagaratnam R, Misiura K, Rebowski G, Amerakoon R, Stec WJ.
    Biochem Biophys Res Commun; 1996 Jan 26; 218(3):930-3. PubMed ID: 8579616
    [Abstract] [Full Text] [Related]

  • 5. [Plasmodium falciparum: antimalarial activities of antisense oligodeoxyribonucleotides targeted to histidine-rich protein genes in vitro].
    Yu XB, Fang JM, Luo SH.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000 Jan 26; 18(4):200-3. PubMed ID: 12567657
    [Abstract] [Full Text] [Related]

  • 6. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
    McKie JH, Douglas KT, Chan C, Roser SA, Yates R, Read M, Hyde JE, Dascombe MJ, Yuthavong Y, Sirawaraporn W.
    J Med Chem; 1998 Apr 23; 41(9):1367-70. PubMed ID: 9554869
    [Abstract] [Full Text] [Related]

  • 7. Structural and immunostimulatory properties of Y-shaped DNA consisting of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Matsuoka N, Nishikawa M, Mohri K, Rattanakiat S, Takakura Y.
    J Control Release; 2010 Dec 20; 148(3):311-6. PubMed ID: 20887761
    [Abstract] [Full Text] [Related]

  • 8. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S, Cohen J.
    Cancer Res; 1990 Oct 15; 50(20):6565-70. PubMed ID: 2208117
    [Abstract] [Full Text] [Related]

  • 9. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
    O'Neil MT, Korsinczky ML, Gresty KJ, Auliff A, Cheng Q.
    J Infect Dis; 2007 Aug 01; 196(3):467-74. PubMed ID: 17597462
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of the effect of retinol on Plasmodium falciparum in vitro.
    Hamzah J, Davis TM, Skinner-Adams TS, Beilby J.
    Exp Parasitol; 2004 Aug 01; 107(3-4):136-44. PubMed ID: 15363939
    [Abstract] [Full Text] [Related]

  • 13. Characterization of antisense oligonucleotides comprising 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA): specificity, potency, and duration of activity.
    Ferrari N, Bergeron D, Tedeschi AL, Mangos MM, Paquet L, Renzi PM, Damha MJ.
    Ann N Y Acad Sci; 2006 Oct 01; 1082():91-102. PubMed ID: 17145930
    [Abstract] [Full Text] [Related]

  • 14. Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.
    Ghosh MK, Ghosh K, Cohen JS.
    Anticancer Drug Des; 1993 Feb 01; 8(1):15-32. PubMed ID: 8386513
    [Abstract] [Full Text] [Related]

  • 15. Antisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum.
    Wanidworanun C, Nagel RL, Shear HL.
    Mol Biochem Parasitol; 1999 Jul 30; 102(1):91-101. PubMed ID: 10477179
    [Abstract] [Full Text] [Related]

  • 16. Efficient delivery of intact phosphodiester oligonucleotides by poly-beta-amino esters.
    Remaut K, Symens N, Lucas B, Demeester J, De Smedt SC.
    J Control Release; 2010 May 21; 144(1):65-74. PubMed ID: 20114066
    [Abstract] [Full Text] [Related]

  • 17. [Inhibition of hepatitis C virus by antisense oligodeoxynucleotide in vitro].
    Liu Y, Chen Z, He N.
    Zhonghua Yi Xue Za Zhi; 1997 Aug 21; 77(8):567-70. PubMed ID: 9772458
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine.
    Thaithong S, Ranford-Cartwright LC, Siripoon N, Harnyuttanakorn P, Kanchanakhan NS, Seugorn A, Rungsihirunrat K, Cravo PV, Beale GH.
    Exp Parasitol; 2001 Jun 21; 98(2):59-70. PubMed ID: 11465989
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.